FDA Withdraws Direct-To-Consumer Ad Guidance, As It Develops Social Media Documents
This article was originally published in The Gray Sheet
Executive Summary
Agency reps updated stakeholders on guidance development efforts related to advertising and promotion during a Food and Drug Law Institute conference in Washington, D.C.
You may also be interested in...
CDRH To Beef Up Monitoring Of Device Ads And Promotions
CDRH will expand its staff devoted to monitoring device advertising and promotions activity as part of a reorganization of its Office of Compliance.
FDA Subject To More Oversight Following User Fee Bill Passage
The legislation, awaiting the signature of the president, will bring greater scrutiny of device center activities by Congress and industry.
Off-Label Questions, Online: FDA Explains How To Handle Them
FDA draft guidance weighs in on web communications, saying that firms must answer off-label-information questions privately, even if the questions arise in a public online forum.